Industry News

Feb 23, 2018
By Pharmaceutical Technology Editors
The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.
Feb 23, 2018
By Pharmaceutical Technology Editors
The agency clarifies recommendations found in ICH Q11 about chemical entities and biotechnology entities.
Feb 22, 2018
By Pharmaceutical Technology Editors
The research partnership will focus on advancing regenerative medicine using porcine bioproducts.
Feb 22, 2018
By Pharmaceutical Technology Editors
The new training center, the Jefferson Institute for Bioprocessing, will prepare engineering students and industry professionals for the field of biologics manufacturing.
Feb 21, 2018
By Pharmaceutical Technology Editors
The agency released draft guidance on the format for electronic submissions of NDA and BLA content regarding the planning of bioresearch monitoring inspections.
Feb 20, 2018
By Pharmaceutical Technology Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 20, 2018
By Pharmaceutical Technology Editors
FDA and CDC are investigating a multi-state Salmonella outbreak that appears to be caused by kratom, a plant used as an opioid substitute.
Feb 15, 2018
By Pharmaceutical Technology Editors
FDA Commissioner Scott Gottlieb issued a statement that FDA will be modernizing regulatory programs in order to advance novel treatments.
Feb 15, 2018
By Pharmaceutical Technology Editors
Researchers at the University of Illinois developed a method to transplant pancreatic islet cells from pigs more easily to treat type I diabetes.
Feb 14, 2018
By Pharmaceutical Technology Editors
The company is voluntarily recalling one lot of Acyclovir Tablet due to packaging that may contain a different product.
native1_300x100
lorem ipsum